Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
23.42
+0.72 (3.17%)
At close: Aug 20, 2025, 4:00 PM
23.42
0.00 (0.00%)
After-hours: Aug 20, 2025, 4:10 PM EDT

Dianthus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21
754645154--
Market Cap Growth
-21.12%318.69%---
Enterprise Value
446364-35--
Last Close Price
23.4221.8010.40--
PS Ratio
170.41103.4854.53--
PB Ratio
2.491.830.91--
P/TBV Ratio
2.491.830.91--
EV/Sales Ratio
91.9058.45---
Debt / Equity Ratio
0.000.000.000.01-
Asset Turnover
0.010.020.020.14-
Quick Ratio
12.8114.9618.099.861.70
Current Ratio
13.1215.2218.439.971.75
Return on Equity (ROE)
-34.71%-32.60%-35.92%-73.25%-
Return on Assets (ROA)
-23.37%-23.01%-22.94%-40.12%-
Return on Capital (ROIC)
-24.49%-24.33%-24.69%-47.27%-
Earnings Yield
-15.22%-13.17%-28.26%--
FCF Yield
-13.31%-12.13%-23.99%--
Buyback Yield / Dilution
-71.34%-546.44%-489.48%78.17%-
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q